Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.440
+0.050 (3.60%)
At close: Dec 20, 2024, 4:00 PM
1.410
-0.030 (-2.08%)
After-hours: Dec 20, 2024, 5:00 PM EST
Outlook Therapeutics Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Revenue | - | - | - | - | - | 8.15 | |
| Revenue Growth (YoY) | - | - | - | - | - | 163.84% | |
| Cost of Revenue | 34.18 | 26.45 | 42.33 | 38.96 | 26.34 | 23.81 | |
| Gross Profit | -34.18 | -26.45 | -42.33 | -38.96 | -26.34 | -15.66 | |
| Selling, General & Admin | 27.1 | 26.67 | 20.74 | 12.77 | 9.97 | 9.37 | |
| Operating Expenses | 27.1 | 26.67 | 20.74 | 12.77 | 9.97 | 9.37 | |
| Operating Income | -61.28 | -53.13 | -63.07 | -51.73 | -36.31 | -25.03 | |
| Interest Expense | -2.19 | -1.56 | -1.49 | -0.94 | -1.76 | -3.47 | |
| Earnings From Equity Investments | -0.09 | -0.01 | -0.05 | -0.05 | - | - | |
| Other Non Operating Income (Expenses) | -27.69 | 0.05 | 0.47 | -0.45 | 1.98 | 2.44 | |
| EBT Excluding Unusual Items | -91.25 | -54.65 | -64.14 | -53.16 | -36.09 | -26.06 | |
| Asset Writedown | - | - | - | - | -0.53 | -11.27 | |
| Other Unusual Items | -2.79 | -4.33 | -1.91 | - | -1.9 | -0.61 | |
| Pretax Income | -94.05 | -58.98 | -66.05 | -53.16 | -38.51 | -37.93 | |
| Income Tax Expense | 0 | 0 | 0 | 0 | -3.27 | -3.41 | |
| Earnings From Continuing Operations | -94.05 | -58.98 | -66.05 | -53.16 | -35.24 | -34.52 | |
| Net Income | -94.05 | -58.98 | -66.05 | -53.16 | -35.24 | -34.52 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | 13.63 | 1.52 | |
| Net Income to Common | -94.05 | -58.98 | -66.05 | -53.16 | -48.87 | -36.04 | |
| Shares Outstanding (Basic) | 16 | 13 | 11 | 8 | 4 | 1 | |
| Shares Outstanding (Diluted) | 16 | 13 | 11 | 8 | 4 | 1 | |
| Shares Change (YoY) | 32.01% | 17.96% | 38.91% | 110.43% | 298.84% | 268.84% | |
| EPS (Basic) | -5.93 | -4.72 | -6.23 | -6.96 | -13.47 | -39.62 | |
| EPS (Diluted) | -5.93 | -4.72 | -6.23 | -6.96 | -13.47 | -39.62 | |
| Free Cash Flow | -64.55 | -42.97 | -56.67 | -54.25 | -31.79 | -32.73 | |
| Free Cash Flow Per Share | -4.07 | -3.44 | -5.34 | -7.11 | -8.76 | -35.98 | |
| Gross Margin | - | - | - | - | - | -192.23% | |
| Operating Margin | - | - | - | - | - | -307.25% | |
| Profit Margin | - | - | - | - | - | -442.41% | |
| Free Cash Flow Margin | - | - | - | - | - | -401.75% | |
| EBITDA | -61.19 | -53.08 | -62.87 | -51.46 | -35.76 | -21.67 | |
| EBITDA Margin | - | - | - | - | - | -265.98% | |
| D&A For EBITDA | 0.1 | 0.04 | 0.2 | 0.26 | 0.55 | 3.36 | |
| EBIT | -61.28 | -53.13 | -63.07 | -51.73 | -36.31 | -25.03 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.